Hasegawa H - Search Results

1

Novel Autoantigens Associated with Lupus Nephritis.

Onishi S, Adnan E, Ishizaki J, Miyazaki T, Tanaka Y, Matsumoto T, Suemori K, Shudou M, Okura T, Takeda H, Sawasaki T, Yasukawa M, Hasegawa H. Onishi S, et al. Among authors: hasegawa h. PLoS One. 2015 Jun 22;10(6):e0126564. doi: 10.1371/journal.pone.0126564. eCollection 2015. PLoS One. 2015. PMID: 26098692 Free PMC article.

2

Transcriptional downregulation of DC-SIGN in human herpesvirus 6-infected dendritic cells.

Niiya H, Azuma T, Jin L, Uchida N, Inoue A, Hasegawa H, Fujita S, Tohyama M, Hashimoto K, Yasukawa M. Niiya H, et al. Among authors: hasegawa h. J Gen Virol. 2004 Sep;85(Pt 9):2639-2642. doi: 10.1099/vir.0.80095-0. J Gen Virol. 2004. PMID: 15302957

3

Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.

Inoue A, Hasegawa H, Kohno M, Ito MR, Terada M, Imai T, Yoshie O, Nose M, Fujita S. Inoue A, et al. Among authors: hasegawa h. Arthritis Rheum. 2005 May;52(5):1522-33. doi: 10.1002/art.21007. Arthritis Rheum. 2005. PMID: 15880599 Free article.

4

Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.

Hasegawa H, Inoue A, Kohno M, Muraoka M, Miyazaki T, Terada M, Nakayama T, Yoshie O, Nose M, Yasukawa M. Hasegawa H, et al. Arthritis Rheum. 2006 Apr;54(4):1174-83. doi: 10.1002/art.21745. Arthritis Rheum. 2006. PMID: 16575871 Free article.

5

Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18.

Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K, Yasukawa M. Kohno M, et al. Among authors: hasegawa h. Biochem Biophys Res Commun. 2006 Sep 1;347(3):827-32. doi: 10.1016/j.bbrc.2006.06.175. Epub 2006 Jul 10. Biochem Biophys Res Commun. 2006. PMID: 16844083

6

[Primary Sjögren's syndrome with recurrent aseptic meningitis].

Matsubara E, Hasegawa H, Kohno M, Sakai I, Yasukawa M, Sada E. Matsubara E, et al. Among authors: hasegawa h. Nihon Naika Gakkai Zasshi. 2006 Aug 10;95(8):1548-50. doi: 10.2169/naika.95.1548. Nihon Naika Gakkai Zasshi. 2006. PMID: 16955941 Japanese. No abstract available.

7

IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.

Muraoka M, Hasegawa H, Kohno M, Inoue A, Miyazaki T, Terada M, Nose M, Yasukawa M. Muraoka M, et al. Among authors: hasegawa h. Arthritis Rheum. 2006 Nov;54(11):3591-600. doi: 10.1002/art.22172. Arthritis Rheum. 2006. PMID: 17075801 Free article.

8

Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice.

Hasegawa H, Inoue A, Muraoka M, Yamanouchi J, Miyazaki T, Yasukawa M. Hasegawa H, et al. Arthritis Res Ther. 2007;9(1):R15. doi: 10.1186/ar2122. Arthritis Res Ther. 2007. PMID: 17284325 Free PMC article.

9

Follicular dendritic cell tumor as an unknown primary tumor.

Yakushijin Y, Shikata H, Kito K, Ohshima K, Kojima K, Hato T, Hasegawa H, Yasukawa M. Yakushijin Y, et al. Among authors: hasegawa h. Int J Clin Oncol. 2007 Feb;12(1):56-8. doi: 10.1007/s10147-006-0626-x. Epub 2007 Feb 25. Int J Clin Oncol. 2007. PMID: 17380443

10

Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.

Tanaka A, Suemaru K, Otsuka T, Ido K, Nishimiya T, Sakai I, Hasegawa H, Inoue T, Murase M, Yasukawa M, Araki H. Tanaka A, et al. Among authors: hasegawa h. Ther Drug Monit. 2007 Apr;29(2):261-4. doi: 10.1097/FTD.0b013e31803bcfd2. Ther Drug Monit. 2007. PMID: 17417082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,906 results

Search Page

Filters